glp 1 analogues names Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 Agonists: New Delivery Methods
Description
Those who took a GLP-1 had a lower risk of complications, including progression to proliferative diabetic retinopathy, diabetic macular edema, vitreous hemorrhage, and neovascular glaucoma
However, if you are more sensitive to side effects, semaglutide could be a better starting point
The goal is not blame
Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns
What to actually do about it The strongest evidence for what changes the body composition equation comes from a randomized, head-to-head, placebo-controlled trial published by Lundgren and colleagues in NEJM in 2021
Weight loss also tends to follow a dose-response pattern, meaning higher doses generally produce greater average reductions in body fat
